Angela M. Kaindl

Prof. Dr. Angela M. Kaindl

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2011 in Developmental Neuroscience
Verified
Journal Article
Open access
PDF file
MCMelinda Czeh
Melinda Czeh
PGPierre Gressens
Pierre Gressens
AKAngela M. Kaindl
Angela M. Kaindl
Microglia, the resident immune cells of the mammalian central nervous system (CNS), play a pivotal role in both physiological and pathological conditions such as the restoration of CNS integrity and the progression of neurodegenerative disorders. Extensive data have been published that describe neuroinflammation by microglial activation to have detrimental consequences on the developing and mature brain. On the other hand, a properly directed and limited inflammatory response is known to be a natural healing process after an insult in several other tissues. Thus, it is not surprising that research results illustrating benefits of neuroinflammation have been emerging over the past decade. Inflammation-mediated benefits for CNS outcomes include mechanisms such as neuroprotection, mobilization of neural precursors for repair, remyelination and axonal regeneration. Here, we review data that highlight the dual aspects of microglia with a focus on the developing brain, i.e. as aggressors potentiating damage and as helpers in the recovery process following CNS damage.

24 April 2012 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
AKAngela M. Kaindl
Angela M. Kaindl
VDVincent Degos
Vincent Degos
SPStéphane Peineau
Stéphane Peineau
EGElodie Gouadon
Elodie Gouadon
VCVibol Chhor
Vibol Chhor
PGPierre Gressens
Pierre Gressens

12 March 2014 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
MHMaja von der Hagen
Maja von der Hagen
MPMark Pivarcsi
Mark Pivarcsi
JLJuliane Liebe
Juliane Liebe
HBHorst von Bernuth
Horst von Bernuth
NDNataliya Didonato
Nataliya Didonato
AKAngela M. Kaindl
Angela M. Kaindl

1 March 2010 in Progress in Neurobiology
Verified
Journal Article
Closed access
AKAngela M. Kaindl
Angela M. Kaindl
SPSandrine Passemard
Sandrine Passemard
PKPavan Kumar
Pavan Kumar
NKNadine Kraemer
Nadine Kraemer
LILina Issa
Lina Issa
PGPierre Gressens
Pierre Gressens

1 January 2022 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
CWClaudia Weiß
Claudia Weiß
AZAndreas Ziegler
Andreas Ziegler
LBLena-Luise Becker
Lena-Luise Becker
JJJessika Johannsen
Jessika Johannsen
HBHeiko Brennenstuhl
Heiko Brennenstuhl
AKAngela M. Kaindl
Angela M. Kaindl

6 August 2016 in eLife
Verified
Journal Article
Open access
BHBianca Hartmann
Bianca Hartmann
TWTimothy Wai
Timothy Wai
HHHao Hu
Hao Hu
TMThomas MacVicar
Thomas MacVicar
LMLuciana Musante
Luciana Musante
AKAngela M. Kaindl
Angela M. Kaindl
Mitochondriopathies often present clinically as multisystemic disorders of primarily high-energy consuming organs. Assembly, turnover, and surveillance of mitochondrial proteins are essential for mitochondrial function and a key task of AAA family members of metalloproteases. We identified a homozygous mutation in the nuclear encoded mitochondrial escape 1-like 1 gene YME1L1, member of the AAA protease family, as a cause of a novel mitochondriopathy in a consanguineous pedigree of Saudi Arabian descent. The homozygous missense mutation, located in a highly conserved region in the mitochondrial pre-sequence, inhibits cleavage of YME1L1 by the mitochondrial processing peptidase, which culminates in the rapid degradation of YME1L1 precursor protein. Impaired YME1L1 function causes a proliferation defect and mitochondrial network fragmentation due to abnormal processing of OPA1. Our results identify mutations in YME1L1 as a cause of a mitochondriopathy with optic nerve atrophy highlighting the importance of YME1L1 for mitochondrial functionality in humans.